FDA’s Bond Increases Intra-Agency Liaison Role
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA Director of Scientific Policy Development Susan Bond will assume a greater role in intra-agency communications.
You may also be interested in...
FDA External Relations Head Pitts Will Leave Agency June 18
Associate Commissioner for External Relations Peter Pitts will join the public relations firm Manning, Selvage & Lee as VP-health affairs. During his 14-month tenure at FDA, the agency adopted a more aggressive communications approach.
Crawford Will Lead A Reorganized FDA As McClellan Leaves For CMS
FDA is implementing a three-deputy commissioner structure on an acting basis to ensure a smooth transition. Selection of a permanent commissioner is unlikely before the November elections.
Pink Sheet Podcast: EUA’s Impact On US FDA, March-In Rights, CBER And Real-Time Oncology Review
Pink Sheet reporters and editor discuss the influence of the emergency use authorization on FDA decisions, another twist in the march-in rights debate, and how CBER is not using the real-time oncology review program.